Low‐ versus high‐concentration intravenous immunoglobulin for children with Kawasaki disease in the acute phase

Abstract

AbstractPurposeFew studies have compared the effects of low‐concentration (5%) and high‐concentration (10%) intravenous immunoglobulin (IVIG) preparations for patients with Kawasaki disease (KD) in the acute phase. The purpose of this study was to compare outcomes between low‐ and high‐concentration IVIG preparations in children with KD, using a national inpatient database in Japan.MethodWe used the Diagnostic Procedure Combination database to identify patients with KD treated with IVIG from April 2012 to March 2020. We identified those receiving high‐ and low‐concentration IVIG preparations as an initial treatment. The outcomes included the proportions of patients with coronary artery abnormalities (CAAs) and IVIG resistance, length of stay, and medical costs. Propensity score‐matched analyses were conducted to compare the outcomes between the 2 groups. Instrumental variable analyses were performed to confirm the results.ResultWe identified 48 046 patients with KD and created 4:1 propensity score‐matched pairs between the low‐ and high‐concentration IVIG groups. There was a significant difference in the percentage with IVIG resistance between the 2 groups (20.6% vs 24.1%; risk difference, 3.5% [95% confidence interval, 2.3‐4.7]; P < .001). However, there was no significant difference in CAAs (1.6% vs 1.6%; risk difference, 0.013% [95% confidence interval, −0.34 to 0.37]; P = .953). The instrumental variable analyses showed similar results.ConclusionsThe proportion of CAAs did not differ significantly between those receiving low‐ and high‐concentration IVIG. To confirm the results of this study, prospective studies adjusting for duration of IVIG administration and duration of observation are needed.